Novartis' First-Quarter Results 2003; Novartis Delivers Strong Growth in First Quarter Despite Weak Economic Environment

| Source: Novartis Novartis

BASEL, Switzerland, April 15, 2003 (PRIMEZONE) -- Novartis (NYSE:NVS) (Other OTC:NVSEF): 


 -- Group sales up 21% in USD (13% in local currencies);
    Pharmaceuticals grows by 18% in USD (10% in local currencies);
    Generics jumps 98% in USD (83% in local currencies)
 -- Group operating income climbs 24%, lifted by further productivity
    and product mix enhancements
 -- Net income at previous first quarter level due to impact of 2002
    loss at associated company Roche, excluding which net income would
    have increased 27%
 -- Increased investment in R&D and successful Business
    Development/Licensing deals add to attractive pipeline

http://reports.huginonline.com/899530/116084.pdf 



            








        

            

                

                    
Mot-clé

                            
                                EARNINGS
                            

                



        




    

        

        
Coordonnées